These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6386014)

  • 21. [Selective action of metabolic drug therapy in mentally retarded children].
    Avrutskaia IG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(3):436-9. PubMed ID: 7395426
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of dopamine agonists in dystonia.
    Teräväinen H; Calne S; Burton K; Beckman J; Calne DB
    Adv Neurol; 1988; 50():571-8. PubMed ID: 3041762
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of nootropic agents on visual functions and lacrimal antioxidative activity in patients with primary open-angle glaucoma].
    Davydova NG; Kuznetsova TP; Borisova SA; Abdulkadyrova MZh
    Vestn Oftalmol; 2006; 122(6):42-5. PubMed ID: 17217203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cerebral circulatory and metabolic improver].
    Otomo E
    Nihon Rinsho; 1993 Nov; 51 Suppl():202-8. PubMed ID: 8283667
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacology of brain circulation and clinical extrapolations. An experimental study of the circulatory and metabolic effects of Hydrosarpan 711].
    Cahn J; Herold M; Borzeix MG
    Sem Hop Ther; 1974 Dec; 50(10):671-82. PubMed ID: 4465918
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of GABA isonicotinoylamide on cerebral circulation].
    Mirzoian RS; Gan'shina TS; Shmuĭlovich LM
    Biull Eksp Biol Med; 1981 Nov; 92(11):573-4. PubMed ID: 7317636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cholinergic drugs and cerebral metabolic activators on memory impairment in old rats.
    Kamei C; Tsujimoto S; Tasaka K
    J Pharmacobiodyn; 1990 Dec; 13(12):772-7. PubMed ID: 2098550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of calcium hopantenate on GABA receptors in the aged rat brain cortex].
    Ogawa N; Kuroda H; Nukina I; Takayama H; Ota Z
    Nihon Ronen Igakkai Zasshi; 1985 May; 22(3):264-5. PubMed ID: 2995708
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cerebral circulatory improvers and metabolic activators].
    Otomo E
    No To Shinkei; 1994 Mar; 46(3):239-44. PubMed ID: 8192938
    [No Abstract]   [Full Text] [Related]  

  • 30. [Changes in the psychoemotional sphere and their correction in trigeminal neuralgia].
    Karlov VA; Megdiatova RS; Vlasenko AG
    Sov Med; 1987; (8):30-2. PubMed ID: 3423959
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cerebral metabolic activator (author's transl)].
    Ishihara N; Gotoh F
    No To Shinkei; 1979 Aug; 31(8):739-49. PubMed ID: 40583
    [No Abstract]   [Full Text] [Related]  

  • 32. [The use of pantogam in patients with moderate cognitive disorders of vascular genesis].
    Mikhaĭlova NA; Kamchatov PR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(12 Suppl 2):47-50. PubMed ID: 20879105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical efficacy of nicergoline in cerebrovascular diseases. Statistical study].
    Guardamagna C; Negri S
    Minerva Cardioangiol; 1972 Nov; 20(11):636-41. PubMed ID: 4566130
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of indeloxazine hydrochloride (YM-08054) on anoxia.
    Yamamoto M; Shimizu M
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):272-81. PubMed ID: 3592867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Some therapeutic effects of GABA in neurology (author's transl)].
    Borromei A
    Riv Patol Nerv Ment; 1974 Aug; 95(4):300-22. PubMed ID: 4157162
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of calcium hopantenate on minute active substances in brain damaged children].
    Haraguchi H; Hata M; Oshikiri M; Yano M; Une K
    Horumon To Rinsho; 1983 Apr; 31(4):357-61. PubMed ID: 6883749
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical and electroencephalographic studies of the effect of nicergoline in cerebrovascular diseases].
    Montanini R; Gasco P; Manfredini G
    Acta Neurol (Napoli); 1973; 28(2):133-49. PubMed ID: 4575428
    [No Abstract]   [Full Text] [Related]  

  • 38. [The role of combat stress in the development of chronic pain syndrom in veterans and its treatment by pantogam active].
    Pal'tsev AI; Torgashov MN; Vorontsova IuS; Baiandina EV; Luniakina SB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):43-6. PubMed ID: 21246890
    [No Abstract]   [Full Text] [Related]  

  • 39. Proceedings: Experimental studies on the action of metabolic and vasoactive substances in the oligemically disturbed brain.
    Gygax P; Meier-Ruge W; Schulz U; Enz A
    Arzneimittelforschung; 1976; 26(6):1245-6. PubMed ID: 989443
    [No Abstract]   [Full Text] [Related]  

  • 40. [Double-blind study based upon a quatitative appreciation scale of treating chronic cerebrovascular disorders].
    Mémin Y; Najean Hueber E
    Therapeutique; 1973 Nov; 49(9):605-8. PubMed ID: 4600040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.